Role of Arl13b-exocyst interaction in ciliogenesis by Moreiras, Hugo António Fragoso, 1990-
Universidade de Lisboa 
Faculdade de Ciências 
Departamento de Biologia Vegetal 
!
!
!
!
!
!
Role of Arl13b-exocyst interaction in 
ciliogenesis 
 
!
Hugo António Fragoso Moreiras 
!
Dissertação 
Mestrado em Biologia Molecular e Genética 
 
2014 
!!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Universidade de Lisboa 
Faculdade de Ciências 
Departamento de Biologia Vegetal 
!
!
Role of Arl13b-exocyst interaction in 
ciliogenesis 
!
Hugo%António%Fragoso%Moreiras%
Dissertação 
Mestrado em Biologia Molecular e Genética 
Sob!a!orientação!científica!de:!
1%Dr.%Duarte%Barral% %
(Professor!Auxiliar!da!Faculdade!de!Ciências!Médicas!da!Universidade!Nova!de!Lisboa;!
Principal)Investigator!no!Membrane)traffic)in)Infection)and)Disease)Group!do!Centro!de!
Estudos!de!Doenças!CrónicasFCEDOC)!
1%Professora%Dra.%Rita%Zilhão%
(Professor!Associado!do!Departamento!de!Biologia!Vegetal!da!Faculdade!de!Ciências!
da!Universidade!de!Lisboa)!
Mestrado!em!Biologia!Molecular!e!Genética!
2014!
!
! I 
Acknowledgements!
 
I would like to express my gratitude to my supervisor, Dr. Duarte Barral, whose 
expertise and knowledge in many areas contributed considerably in the development of my 
master thesis in Membrane Traffic in Infection and Disease lab. 
 
 I would like to thank Dra. Rita Zilhão from Faculdade de Ciências da Universidade de 
Lisboa for her constant support and interest showed in my work during the past year.  
 
A special thanks also to Dra. Cecília Seixas, who taught me to think and work as a 
scientist. Without her teaching, patience and support during my period in the lab this thesis 
would not have been possible.  
 
I also want to leave a special word for Ana Portelinha, Carolina Matos, Cristina 
Casalou, Cristina Escrevente, Elsa Seixas, Francisco Pereira, Lilia Espada, Maria Serrano, 
Margarida Correia, Nuno Claudio and Remy Cardoso. You help me to growth as a scientist 
and as a person and I am very grateful to had the change to meet you all and work and learn 
with you.  And off course I would never forget the incredible moments we spend together in 
the lab and in all the activities we made together. 
 
I would like also to acknowledge Dra. Susana Lopes form Cilia Regulation & Disease 
lab for the opportunity she gave me to work with zebrafish in her lab. I also would like to 
thank Pedro Sampaio and Petra Pintado, as well as the other members of the group, for 
teaching me the tecnhiques and helping me in the interpretation of the results. I would like to 
thank all the staff of the fish-facility for all the help and support. 
 
To all my colleagues in CEDOC with whom I share great moments and were always 
there for support and motivation. Without the amazing team that this institution provides from 
the researchers until the managing office every step of this journey would have been more 
difficult. I wish you all the best luck in your life and that we could work together in the future. 
 
I like to thank my friends from the University and from my hometown that directly or 
indirectly, help and support me during the last years leading to this moment. 
 
Finally, I want to thank my parents and my brother for the unconditional support. 
Without you I will never be here and will never become the person I am today. You know I 
love you with all my heart and that my biggest goal in life is to always see you proud. 
 II 
Table of Contents 
Acknowledgements......................................................................................I 
Table of contentes.......................................................................................II 
List of figures..............................................................................................III 
Resumo Alargado.......................................................................................VI 
Abstract.......................................................................................................IX 
Abreviations.................................................................................................X 
1 Introduction ...................................................................................................................... 1 
1.1 Types of cilia .............................................................................................................. 1 
1.1.1 Ciliary structure ..................................................................................................... 2 
1.1.2 Ciliary membrane .................................................................................................. 3 
1.2 Vesicular trafficking .................................................................................................. 3 
1.2.1 Small G proteins ................................................................................................... 5 
1.2.2 Arl proteins and ciliogenesis ................................................................................. 6 
1.3 Ciliary trafficking ....................................................................................................... 7 
1.3.1 Intraflagellar transport ........................................................................................... 7 
1.3.2 Transport from intracellular compartments to the cilium ....................................... 7 
1.4 Ciliopathies ................................................................................................................ 9 
1.4.1 Joubert syndrome ................................................................................................. 9 
2 Hypothesis and objectives ............................................................................................ 11 
3 Materials and Methods .................................................................................................. 12 
3.1 Cell Culture .............................................................................................................. 12 
3.2 Silencing assays ..................................................................................................... 12 
3.3 Plasmids transfection and constructs .................................................................. 13 
3.4 In vitro protein translation ...................................................................................... 13 
3.5 Immunoprecitation .................................................................................................. 13 
3.6 GFP-pull-down ......................................................................................................... 13 
3.7 Immunobloting ........................................................................................................ 14 
3.8 Immunofluorescence .............................................................................................. 14 
3.9 RNA extraction, complementary DNA production and real-time quantitative 
PCR . .................................................................................................................................. 15 
4 Results ............................................................................................................................ 16 
4.1 Characterization of the interaction between Arl13b and exocyst complex ....... 16 
4.1.1 Sec8 is an Arl13b effector ................................................................................... 16 
4.1.2 Sec8 and Arl13b interact directly ........................................................................ 17 
4.1.3 Exo70 co-immunoprecipitated with Arl13b .......................................................... 18 
4.1.4 Sec8 and Arl13b interaction is abolished by Arl13b N- or C-terminal domain 
truncation ........................................................................................................................ 19 
4.2 Function of Arl13b-exocyst complex in ciliogenesis ........................................... 22 
4.2.1 Arl13b and Sec8 depletion affect cilia formation and lenght in NIH-3T3 cells .... 22 
5 Discussion and future perspectives ............................................................................ 24 
6 Bibliography ................................................................................................................... 29 
!
 
Supplementary data..................................................................................-1-!!!
! III 
List of Figures !
! Figure 1 – Primary cilia structure. Schematic representation of the structure of the 
primary cilium showing the basal body, axoneme, ciliary membrane, transition zone 
and ciliary pocket with clathrin-coated pits (CCP) and clathrin-coated vesicles (CCV) 
formation. Taken from Ke et al, 2014 (3)…………………………………………………..1 
! Figure 2 – Arl small G proteins function as molecular switches. Exchange of 
GDP for GTP is catalyzed by guanine nucleotide exchange factors (GEF), leading to 
a conformational change. The active conformation is recognized by effector proteins 
and is converted to the inactive form through GTP hydrolysis, catalyzed by a 
GTPase-activating protein (GAP). Taken from Stenmark 2009 (20). ………………….5 
! Figure 3 – Models for the trafficking of membrane proteins to cilia. (1) Direct 
trafficking from the Golgi to the ciliary pocket. (2) Transport to the cell surface 
followed by lateral transport into the cilium. (3) Internalization into the ERC (recycling 
pathway) and trafficking to the ciliary pocket. Taken from Milenkovit et al, 2009 
(51)………………………………………………………………………………………….....8 
! Figure 4 – Sec8 and Arl13b co-immunoprecipitation in total cell lysates of 
ciliated and non-ciliated cells. Total cell extracts were prepared and used for co-
immunoprecipitation. Immunoprecipitates were resolved by SDS-PAGE. (A) IMCD3 
cells (600 µg protein) after pre-incubating with no nucleotide (left lane), GTPγS (0,5 
mM; 2nd lane), GDP (5 mM, 3rd lane) or a non-specific rabbit IgG, as control (4th lane), 
samples were immunoprecipitated with Arl13 follow by immunoblotting with anti-Sec8 
antibody. (B) MDCK cells prepared as described in (A). (C) NIH-3T3 cells prepared 
as described in (A). (D) IMCD3 cells (600 µg protein) immunoprecipitated with Sec8 
or a non-specific IgG, as control, follow by immunoblotting with anti-Arl13b antibody. 
Asterisks (*) indicate the denatured heavy chains, absent in the cell lysate 
(input).………...………………………………………………………………..…………….17 
! Figure 5 – Sec8 and Arl13b interact directly. (A) Sec8-Myc and Arl13b-FLAG were 
in vitro-translated using the transcription and translation (TNT) T7 coupled 
reticulocyte lysate system. Five percent of the input was resolved by SDS-PAGE and 
analyzed by immunoblotting with anti-Sec8, anti-Myc, anti-Arl13b or anti-FLAG 
antibodies. As a control, a TNT reaction without DNA as template was analyzed to 
distinguish the endogenous levels of the proteins in the reticulocyte lysates from the 
in vitro-translated proteins. (B) Immunoprecipitation with anti-FLAG antibody was 
performed using as input a mixture of the in vitro-translated proteins, in the presence 
of GTPγS. Immunoprecipitates (lane 1) were analyzed by immunoblot with anti-Myc, 
anti-Sec8 or anti-FLAG antibodies. As a negative control, immunoprecipitations were 
 IV 
performed with an irrelevant mouse IgG1 (IgG) (lane 2), or with an anti-FLAG 
antibody using as input a TNT reaction with no DNA as template that was mixed, in 
the presence of GTPγS, with in vitro-translated Arl13b-FLAG (lane 3). Asterisks (*) 
indicate in vitro-translated Sec8-Myc and the pound (#) signs indicate endogenous 
Sec8.…………………………………………………………………………………..……..18 
! Figure 6 – Exo70 co-Immunoprecipitates with Arl13b in MDCK and NIH-3T3 
cells. (A) Total cell lysates from MDCK cells (800 µg protein) were 
immunoprecipitated with anti-Arl13b antibody after pre-incubation with GTPγS (0,5 
mM; left lane), or with a non-specific rabbit IgG as a control, also pre-incubated with 
GTPγS (0,5 mM; right lane). (B) Total cell lysates from NIH-3T3 cells (800 µg protein) 
were immunoprecipitated with anti-Arl13b antibody after pre-incubation with GTPγS 
(0,5 mM; left lane), or GDP (5 mM; right lane). Immunoprecipitates were resolved by 
SDS-PAGE followed by immunoblotting with anti-Exo70 antibody for both (A) and 
(B).……...........………………………………………...…………………………………….19 
! Figure 7 – Arl13b-GFP pull-downs. (A) Cell lysates from HeLa cells (80 µg 
protein) overexpressing Arl13b-GFP full length, Arl13b[1-193]-GFP or 
Arl13b[194-428]-GFP were resolved by SDS-PAGE and immunoblotted with 
anti-GFP antibody. (B) Cell lysates from HeLa cells (800 µg protein) 
overexpressing Arl13b-GFP full length, Arl13b[1-193]-GFP or Arl13b[194-428]-
GFP were immunoprecipitated with GFP-trap beads to pull-down Arl13b 
proteins tagged with GFP. Asterisks (*) indicate the band for each 
construct..………………………………………..………….......…………………..20 
! Figure 8 – Characterization of Sec8 interaction with Arl13b truncation mutants 
in the presence of GTPγS, GDP or no nucleotide. (A) Total lysates from HeLa cells 
overexpressing Arl13b-GFP full-length, Arl13b[1-193]-GFP or Arl13b[194-428] were 
immunoprecipitated from total cell lysates (800 µg protein) with GFP-trap beads, after 
pre-incubation with GTPγS (0,5 mM), GDP (5 mM) or no nucleotide. As a negative 
control we used total cell lysates from HeLa cells overexpressing GFP pre-incubated 
with GTPγS (0,5 mM) to set the background level of unspecific binding of Sec8 to the 
beads. Immunoprecipitates were resolved by SDS-PAGE, followed by immunoblotting 
with anti-Sec8 and anti-Exo70 antibodies. (B) Quantification of the bands intensities 
for Sec8 shown in (A), using ImageJ software and normalized for GFP levels. (C) 
Quantification of the bands intensities for Exo70 shown in (A), using ImageJ software 
and normalized for GFP levels.………….………………………………………...……...21 
! Figure 9 – Defects in ciliogenesis upon depletion of Arl13b and Sec8. 
Normalized histogram showing the cilia length measured in NIH-3T3 cells transfected 
! V 
with siRNA pools to silence Sec8 and Arl13b. A pool of siRNA control was used as 
control..…………………...…………………………..…………………………..………….22 
! Supplementary Figure 1 -  Sec8 is an Arl13b effector in non-ciliated cells. Total 
cell extracts from HeLa cells were immunoprecipitated with anti-Arl13b antibody in the 
presence of non-hydrolyzable GTP (GTPγS) or GDP. Immunoprecipitates were 
analyzed by SDS-PAGE and immunoblot with anti-Sec8 antibody…………………...-1- 
! Supplementary Figure 2 - Schematic representation of the different domains of 
Arl13b. The Arf domain is responsible for the molecular exchanges between GTP 
and GDP, changing the protein between an inactive and active state to bind effectors. 
On the other hand coiled coil domain and proline rich-region are responsible for 
stabilize the protein conformation to allow the molecular switch between GTP and 
GDP. The mutant Arl13b [1-193]-EGFP contains only the Arf domain of the protein 
and the mutant Arl13b [194-428]-EGFP contains the coiled coil domain and the 
proline-rich region…………………………………………………………………………..-1- 
! Supplementary Figure 3 – Arl13b-GFP pull-down efficiency. Cell lysates from 
HeLa cells (800 µg protein) overexpressing Arl13b-GFP full length, Arl13b[1-193]-
GFP or Arl13b[194-428]-GFP were immunoprecipitated with GFP-trap beads to pull-
down the Arl13b proteins tagged with GFP after pre incubation with GTPγS, or GDP 
or without any nucleotide (No Nucl.). Proteins in the immunoprecipitations were 
resolved by SDS-PAGE and immunblot with anti-GFP antibody. Asterisks (*) indicate 
the specific band for each construct……………………………………………………...-2- 
! Supplementary Figure 4 – Quantification of silencing level by qRT-PCR. (A) 
Percentage of relative mRNA expression for Arl13b determined by qRT-PCR  (B) 
Percentage of relative mRNA expression for Sec8 determined by qRT-PCR……….-2- 
 
 
 
 
 
 
 
 
 
 
 VI 
 
Resumo Alargado 
 
Os cílios primários são organelos sensoriais expostos à superfície da maioria das 
células eucarióticas. Estes funcionam como estruturas semelhantes a antenas, detectando e 
transmitindo sinais químicos provenientes do ambiente extracelular para o interior da célula. 
A sua correcta formação e funções sensoriais são fundamentais para o adequado 
desenvolvimento embrionário e pós-natal, bem como para a homeostase dos tecidos no 
adulto. De facto, diversas doenças humanas, conhecidas por ciliopatias, devem-se a 
defeitos no cílio primário. Este organelo é constituído por um axonema que se forma a partir 
do corpo basal, originado pelo centríolo-materno da célula, e uma membrana ciliar que 
encerra uma pequena porção do citoplasma designado por ciliopasma. A membrana ciliar e 
a membrana plasmática são topologicamente contínuas mas diferem na sua composição 
lipídica. A membrana ciliar contém vários receptores de sinalização celular, canais iónicos e 
proteínas de transporte que tornam este organelo numa autêntica antena celular.   
Até ao momento, ainda não é totalmente conhecido o conjunto de proteínas que 
regula o processo de montagem do cílio. Várias pequenas proteínas G da superfamília Ras 
foram implicadas neste processo. Estas proteínas são conhecidas por regularem as vias de 
tráfego intracelular, assegurando o transporte correcto de moléculas entre compartimentos 
delimitados por membranas. O cílio primário é um desses compartimentos, e é sabido que 
as proteínas ciliares são transportadas do citoplasma até ao cílio através destas vias de 
tráfego intracelular, uma vez que este organelo não possui maquinaria para realizar a 
síntese proteica. Em particular, proteínas da família “Arf-like” (Arl) tais como a Arl3, Arl6 e 
Arl13b foram associadas ao cílio primário. Mutações nestas proteínas causam distrofia e 
disfunção renal, obesidade, polidactilia, entre outros defeitos característicos de ciliopatias.  
O nosso grupo descobriu recentemente que a Arl13b tem um papel na regulação de 
tráfego endocítico de reciclagem. Por outro lado, mutações do gene que codifica a Arl13b 
provocam síndrome de Joubert, uma ciliopatia caracterizada por defeitos neurológicos. Em 
ratinhos, a mutação de Arl13b causa letalidade embrionária devido a falhas na via de 
sinalização “Sonic Hedgehog”, presumivelmente causadas por anomalias na estrutura dos 
cílios primários. Dado que uma das vias que as proteínas ciliares utilizam para chegar ao 
cílio depende do tráfego endocítico de reciclagem, os nossos resultados que sugerem um 
papel da Arl13b na regulação desta via poderão contribuir para explicar os defeitos no cílio 
primário que advêm de mutações na Arl13b. Sendo assim, é possível que a Arl13b tenha um 
papel no endereçamento/ancoragem de vesículas endocíticas de reciclagem, transportando 
proteínas ciliares para a região periciliar.  
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Para além disso, é sabido que as proteínas G quando estão no seu estado activo ou 
ligadas a GTP efectuam as suas funções ligando-se a proteínas designadas por efectores. 
O nosso grupo obteve evidências sólidas de que Arl13b interage com o exocisto, através da 
sua subunidade Sec8. O exocisto é um complexo formado por oito subunidades que 
participa na ligação e ancoragem de vesículas provenientes da rede trans-Golgi e do 
compartimento endocítico de reciclagem. Recentemente, a subunidade Exo84 do exocisto 
foi identificada como mutada em pacientes de síndrome de Joubert e através da subunidade 
Sec10 foi comprovado que o exocisto está envolvido na formação de cílios. Sendo assim, 
colocámos como hipótese que o papel da Arl13b no tráfego de proteínas ciliares para a 
região periciliar ocorra através da sua interação com o exocisto.  
Desta forma, o nosso objectivo é estudar o papel da interacção entre Arl13b e o 
exocisto na ciliogénese e no tráfego ciliar. O nosso primeiro objectivo foca-se na 
caracterização da interação entre Arl13b e Sec8. O segundo objectivo concentra-se no 
papel da interação Arl13b-exocisto na formação de cílios.  
Os nossos resultados provam que o Sec8 é uma efector da Arl13b, uma vez que a 
ligação entre as proteínas aumenta na presença de GTP, em linhas celulares de mamífero e 
que esta interação é independente da presença de cílio. Mostramos também através da 
síntese in vitro de Arl13b-FLAG e Sec8-Myc que a interação entre estas proteínas é directa 
e que não necessita da presença das outras subunidades do complexo. Para além disso, 
observamos também que tanto o domínio N-terminal como o C-terminal da Arl13b são 
necessários para garantir que esta interação ocorra, uma vez que o domínio N-terminal é 
responsável pela ligação ao efector e o domínio C-terminal é responsável por estabilizar a 
proteína e garantir a alteração entre a forma activa e inactiva da mesma garantido a troca 
entre GTP e GDP. São necessários mais estudos para determinar que região da Arl13b é 
responsável pela viabilidade da interação com o exocisto, sendo para isso necessário 
produzir novos plasmídeos de Arl13b com deleções mais pequenas e com mutações 
pontuais para que a conformação da proteína quando expressa nas células não sofra 
alterações tão drástica e seja possível determinar a região de interação. Vimos também que 
outra subunidade do exocisto, o Exo70, é co-immunoprecipitada com Arl13b. Este resultado 
levanta uma nova hipótese em que o Sec8 medeia a interação entre a Arl13b e todo o 
complexo exocisto. Por ultimo, mostramos também pela primeira vez que o Sec8 é 
necessário para a correta ciliogénese, uma vez que ao silenciarmos o Sec8 obtemos uma 
redução na percentagem de células ciliadas . Este fenótipo não é tão acentuado como o 
observado aquando do silenciamento da Arl13b mas permite especular que as duas 
proteínas possam estar envolvidas na mesma via de transporte de proteínas necessárias 
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para a correta formação do cílio. Este resultado reforça a ideia de que a Arl13b é uma peça 
chave na formação e manutenção da correta biologia ciliar. 
Um colaborador deste projeto observou uma interação genética sinérgica entre a 
Arl13b e Sec10 indicando que estas proteínas participam num via comum ou paralela. Em 
conclusão, com os resultados apresentados neste trabalho, com as informações obtidas a 
partir do nosso colaborador e com o facto de que Arl13b regula o tráfego endocítico de 
reciclagem, nós propomos um modelo onde a Arl13b e o exocisto estão envolvidas no 
transporte de proteínas ciliares originárias do compartimento endocítico de reciclagem até 
ao interior do cílio. No nosso modelo, o processo baseia- se em dois passos: o Sec8 numa 
primeira fase é responsável pela seleção e transporte de vesículas contendo Arl13b até à 
região periciliar;  numa segunda fase Exo70 é responsável pela fusão dessas vesículas com 
a membrana ciliar permitindo a libertação das proteínas ciliares no cilioplasma.  
Mais estudos são necessários para testar esta hipótese e comprovar o modelo 
proposto. Os resultados aqui apresentados e os estudos futuros propostos irão fornecer a 
base para melhor compreender e interpretar a pleiotropia fenotípica e etiologia do síndrome 
de Joubert. 
 
 
Palavras-chave: Cílio, Arl13b, exocisto, imunoprecipitação, ciliogénese, tráfego vesicular, 
pequenas proteínas G, ciliopatias e síndrome de Joubert. !!!!!!!!!!!!
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Abstract !
Primary cilia are sensory organelles present on nearly every eukaryotic cell. Arl13b 
belongs to the Arf family of small G proteins. Mutations in this protein were identified in 
patients with Joubert syndrome, a ciliopathy characterized by neurological defects combined 
with polydactyly and cystic kidneys. Nevertheless, the precise role of Arl13b in ciliogenesis 
remains elusive. 
We found that Sec8, a subunit of the exocyst, interacts with Arl13b. The exocyst is an 
octameric complex involved in the tethering of post-Golgi vesicles at their site of fusion, and it 
has been shown to be required for cilia formation. Interestingly, it was identified in a family 
with Joubert syndrome amutation in one of the subunit of the exocyst. Furthermore we show 
that Sec8 is a bona fide effector of Arl13b, since it binds only to the activated form of Arl13b, 
and that the interaction is direct. We proved that both the N- and C- terminal of Arl13b are 
required for the interaction with Sec8. Moreover, we found that Exo70, another subunit of the 
exocyst, also co-immunoprecipitates with Arl13b, suggesting that Sec8 mediates the 
interaction of Arl13b with the exocyst complex. Regarding the ciliogenesis defects, we show 
for the first time that silencing of Sec8 causes an abrogation in cilia formationTogether, these 
results suggest that Arl13b and exocyst function together in the same pathway during cilia-
related processes leading to functional cilia. Since we and others found that Arl13b are 
involved in endocytic recycling trafficking form the endocytic recycling compartment, it is 
possible that both proteins work together in the transport of recycling vesicles containing 
ciliary proteins from the endocytic recycling compartment toward primary cilia. 
 
 
Keywords: Cilia, Arl13b, exocyst, immunoprecipitation, ciliogenesis, vesicular trafficking, 
small G proteins, ciliopathies and Joubert syndrome.!!!!!!!!!!!
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1 Introduction 
1.1 Types of cilia 
 
Cilia are primordial eukaryotic structures, present on the surface of most mammalian 
cell types. These antenna-like projections are known to be essential for several signalling 
cascades, such as Sonic Hedgehog (Shh), Wingless-int (Wnt), Platelet-derived Growth 
Factor (PDGF) and Hippo (1–3). 
Cilia are composed by an axoneme that extends from a basal body, is derived from 
the mother centriole and a ciliary membrane that encloses a small fraction of the cell 
cytoplasm called the cilioplasm (Figure 1). The ciliary membrane contains several signalling 
receptors, ion channels and transport proteins, as well as some of their downstream effectors 
(2, 4, 5). The ciliary and plasma membranes are topologically continuous but differ in their 
lipoprotein composition (1, 3, 6, 7). Several important structures localize to the base of the 
cilium: the ciliary pocket, an invagination found at the junction of the plasma membrane and 
the ciliary membrane where clathrin-coat pits and vesicles accumulate; the septin ring, 
transition fibers, and the transition zone (3, 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Primary cilia structure. Schematic representation of the structure of the primary cilium showing the 
basal body, axoneme, ciliary membrane, transition zone and ciliary pocket with clathrin-coated pits (CCP) and 
clathrin-coated vesicles (CCV) formation. Taken from Ke et al, 2014 (3). 
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Cilia can be classified into two main categories: motile and primary. The axoneme of 
motile cilia consists of a set of 9 microtubules doublets with a microtubule central pair, 
usually referred to as a “9+2” structure (1–3). In contrast, the axoneme of primary cilia 
consists in a “9+0” structure, without a central pair (1, 2, 8). Additionally, motile cilia are 
usually longer than primary cilia, which typically have 5–10 µm in length (8).  
Motile cilia are usually present in multiple copies and can be found in respiratory 
epithelia, oviduct, brain ventricles and sperm (2, 9). They bend in a sine-wave fashion to 
generate fluid movement or cell propulsion, regulating embryonic left-right patterning, 
clearing airway mucus and generating in cerebrospinal fluid movement (1, 10, 11). 
Primary cilia are usually present in a single copy per cell and can be found in 
epithelial and endothelial cells, connective tissues and muscle cells as well as neurons (2, 9). 
By being involved in several signalling cascades they regulate processes such as 
embryogenesis, tumorigenesis, tissue homeostasis, cell migration, differentiation, cell 
division, and apoptosis, as well as kidney function, vision and smell (2, 9, 11).  
Furthermore, primary cilia present in the node are motile and generate a fluid flow 
responsible for defining the left-right patterning during organogenesis. Thus, they can be 
considered a third group of cilia, the nodal cilia (8, 12). 
1.1.1 Ciliary structure 
 
 Ciliogenesis is triggered when the centrosome migrates towards the cell surface 
during the G0 and G1 phases of the cell cycle. The mother and daughter centrioles of the 
basal body are connected by 2–4 striated rootlets and consist of 9 sets of triplet 
microtubules, designated A, B, and C and named according to the distance from the center 
of the centrosome (1, 3). 
When the mother centriole migrates to the cell membrane, it anchors to the plasma 
membrane and then differentiates into the basal body of the primary cilium. The A and B 
microtubules protrude from the cell surface to form the axoneme and C microtubules 
terminate before the axoneme starts at a region known as the transition zone (TZ) (1, 3, 9).  
The TZ is found just above the basal body and is essential for the regulation of ciliary 
protein composition. The microtubule doublets at the TZ are attached to the ciliary 
membrane by Y-shaped links, forming a membrane specialization called the ciliary necklace 
(3, 5, 9).  The TZ is formed by transition fibers and a septin ring that function together to 
provide a large docking site around the base of the cilium for vesicles and protein complexes. 
Importantly, the TZ prevents the exchange of material between the cytoplasm and the 
axoneme. This is achieved due to a nine-bladed propeller-like structure with a 60 nm space 
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between two consecutives sheets, known as the distal appendages where, in theory, large 
protein complexes can fit but not vesicles. Thus, the TZ serves as a diffusion barrier, through 
which only selected proteins are allowed to pass into the cilium (1, 5, 13, 14). 
As referred previously, the internal structure of primary cilia is composed by the 
axoneme, the core of these organelles. The axoneme consists of a complete A-microtubule, 
composed by 13 parallel protofilaments, and an adjacent incomplete B-microtubule, 
composed by 10 protofilaments. Each protofilament is formed by the polymerization of α- and 
β-tubulin heterodimers from the base to the distal tip of the cilia (1, 15). 
Several post-translational modifications are required in order to establish functional 
axoneme microtubules, including acetylation, palmitoylation, tyrosination/detyrosination, 
glutamylation, and glycosylation. Microtubule acetylation is the most frequent post-
translational modification and has been associated with cilia stabilization (3, 16, 17). Indeed, 
acetylated tubulin staining is commonly used to identify cilia.  
1.1.2 Ciliary membrane 
 
Primary cilia emerge from the cell membrane by two different ways: one is based on 
the direct protrusion of cilia from the membrane into the extracellular milieu upon anchoring 
of the basal body to the cell membrane; the second establishes that primary cilia are partially 
buried intracellularly and emanate from a membrane invagination termed the ciliary pocket 
(3). This membrane domain is associated with clathrin-coated pits and vesicles, indicating 
that this is an active site for vesicular trafficking and endocytosis (3, 14). 
The ciliary membrane is known to be enriched in several signalling receptors like the 
G-protein-coupled receptors (GPCRs), which consist of a single polypeptide that is folded 
into a globular shape and polycystins that function as a Ca2+-permeable cation channel, and 
are only present in cilia. Phosphatidylinositol-4-phosphate adaptor protein-2 (FAPP2) was 
shown to be involved in the transport of lipidrafts, a component of the diffusion barrier that 
controls differences in protein content between the ciliary and plasma membranes. 
Furthermore, FAPP2 is necessary for ciliogenesis and when depleted leads to an 
accumulation of vesicles in the basal body region, suggesting that lipidrafts are necessary for 
ciliary transport and consequently cilia formation (6, 11, 13, 18).  
1.2 Vesicular trafficking 
 
Vesicular transport involves the budding of a vesicle containing sorted cargo from a 
donor compartment; movement of the vesicular carrier via cytoskeletal filaments such as 
microtubules and/or actin towards a target compartment; tethering and docking of the vesicle 
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with the target compartment membrane in a close physical association; and finally fusion of 
the carrier with the acceptor compartment, releasing the cargo into the lumen of the target 
compartment (19, 20). 
Vesicular trafficking pathways are usually separated into two main routes: a) the 
secretory pathway starting at the endoplasmic reticulum (ER) and ending at the plasma 
membrane (PM), passing through the Golgi apparatus; and b) the endocytic pathway from 
the PM to lysosomes, through early and late endosomes (EE, LE). Anterograde and 
retrograde routes between the trans-Golgi network (TGN) and endosomes connect both 
pathways. Through the endocytic pathway cells internalize extracellular material, ligands and 
plasma membrane proteins and lipids. The endocytic recycling pathway is also responsible 
for controlling the composition of the plasma membrane. After endocytosis, cargo is 
delivered to the early/sorting endosome from where it can be recycled to the PM by a fast 
recycling pathway, or sorted to the endocytic recycling compartment (ERC) to follow a slow 
recycling route from the ERC to the plasma membrane. Cargo that is not recycled is routed 
to late endosomes and lysosomes for degradation or to the TGN (21, 22). Endocytic 
recycling pathways are important for a wide range of processes like cell migration (23) and 
ciliogenesis (24). 
Eukaryotic cells have evolved strategies to transfer cargo between different 
membrane-bound compartments in a specific and regulated manner. This allows them to 
display a spatial and temporal organization of many cellular processes that is controlled by 
small GTP-binding proteins (G proteins) of the Ras superfamily, among others. Each step of 
vesicular trafficking requires a specific set of regulatory molecules. Vesicle budding and 
cargo selection involve the recruitment of large multi-subunit protein complexes, termed 
coats, such as clathrin or Coat Protein Complexes I and II (COPI and COPII) (25, 26). After 
the vesicles pinch off the donor compartment, they are uncoated and transported along 
microtubules and/or actin filaments, propelled by motor proteins. Kinesin motors guide the 
anterograde transport of vesicles, from the center of the cell towards the periphery, to the 
microtubules plus-ends. In contrast, dynein motors guide the retrograde transport towards 
the microtubules minus-ends (21). Tethering/docking of vesicles to acceptor compartments is 
regulated by tethering protein complexes like the exocyst, the conserved oligomeric Golgi 
(COG) and the Golgi-associated retrograde proteins (GRAP) (27). Finally, fusion of the 
vesicle with the acceptor compartment membrane is mediated by proteins called SNAREs 
(soluble N-ethylmaleimide-sensitive factor activating protein receptor) (28, 29). These 
integral membrane proteins can be classified as vesicular (v-) or target (t-) SNAREs, 
according to their localization, in the transport vesicle or in the target membrane, respectively 
(30). Importantly, the correct transport between intracellular compartments is ensured 
through a combination of these molecular players. Moreover, these proteins localize 
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specifically to different intracellular compartments and are commonly used as markers that 
allow their identification.  
1.2.1 Small G proteins 
 
Structurally, all small G proteins are characterized by four conserved domains for 
guanine nucleotide binding and GTPase activities and a domain for interaction with 
downstream effectors (20, 31, 32). The Ras superfamily of small G proteins can be divided 
into five different major families: Ras (Ras sarcoma), Rho (Ras homologous), Ran (Ras-like 
nuclear), Rab (Ras-like in the brain), and Arf (ADP-ribosylation factor) (31–34).  
The Arf family includes Arl (Arf-like), Arp (Arf-related proteins) and Sar (Secretion-
associated and Ras-related) proteins that are involved in vesicle formation at the Golgi and 
regulation of membrane traffic through the recycling pathways regulation and also in 
cytoskeleton rearrangement (32, 34, 35). 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Arl small G proteins function as molecular switches. Exchange of GDP for GTP is catalyzed by 
guanine nucleotide exchange factors (GEF), leading to a conformational change. The active conformation is 
recognized by effector proteins and is converted to the inactive form through GTP hydrolysis, catalyzed by a 
GTPase-activating protein (GAP). Taken from Stenmark 2009 (20).  
 
Small G proteins function as molecular switches that alternate between two 
conformational states: the guanosine triphosphate (GTP)-bound or active state, and the 
guanosine diphosphate (GDP)-bound or inactive form (Figure 2) (20, 32, 34). When 
activated, small G proteins suffer conformational changes in switch I and switch II regions 
that allow effector binding (20, 36). Besides these changes, Arf family proteins suffer an 
additional conformational change in the N-terminal region, allowing these proteins to interact 
with membranes when in their active state (34, 35). 
Conversion of GDP-bound state to GTP-bound state is catalyzed by guanine 
nucleotide exchange factors (GEFs) that recognise specific residues in the switch regions 
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and favour the GDP release. This is considered a rate-limiting step since the GEF need to be 
activated by an upstream signal to catalyze this reaction. The switch occurs when GTP binds 
to the protein, immediately after GDP has been released. On the other hand, the conversion 
of the GTP-bound to the GDP-bound form occurs in a faster way, since the GTP is 
hydrolyzed by the GTPase intrinsic activity that most of these proteins possess and is also 
facilitated by the catalytic activity of GTPase-activating proteins (GAPs), leading to the 
release of the downstream effectors. Thus, with this cycle of activation and inactivation, small 
G proteins transduce an upstream signal to a downstream effector (19, 20, 32, 34). 
1.2.2 Arl proteins and ciliogenesis 
 
Several small G proteins have been shown to be involved in cilia formation and 
function. In particular, three members of the Arl subfamily, have been associated with 
ciliogenesis and cilia signalling (37). Arl3 was found to negatively regulate ciliogenesis (38). 
Arl6 is central for cilia signalling but not essential for cilia formation (39, 40). Arl13b was 
demonstrated to be required for ciliogenesis (15). Importantly, Arl6 and Arl13b were identified 
to cause diseases in humans when mutated, leading to Bardet-Biedl syndrome (BBS) and 
Joubert Syndrome (JBTS), respectively. 
Arl13b is an unusual Arl protein. Whereas most members of Arl subfamily are 
approximately 20 kDa in mass and composed by only the guanine nucleotide-binding domain 
(41–43), this protein has a long C-terminal domain that contains a coiled-coil motif and a 
proline-rich region. Consequently, the molecular weight of Arl13b is approximately 48 kDa. It 
has been shown that the N- and C-terminal domains of Arl13b are required for its ciliary 
localization (10). Furthermore, Arl13b has also been implicated in endocytic recycling traffic 
(22), cellular differentiation (44) and cell migration (23). 
Sequence analyses revealed that Arl13b contains a palmitoylation motif in its N-
terminal domain that was shown to be required for membrane association, and also a 
SUMOylation motif that was found to regulate the targeting of different sensory receptors, 
and therefore downstream signalling (17, 45). 
Studies in hnn mouse mutants, carrying a null allele of Arl13b, show that this protein 
is crucial for the organization of outer-doublet microtubules of the ciliary axoneme (15), since 
the B-microtubules are neither closed nor attached to the A-microtubules. This suggests that 
one of the functions of Arl13b is the assembly and maintenance of the ciliary axoneme (46). 
However, the mechanism by which Arl13b regulates this function is unknown. 
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1.3 Ciliary trafficking 
 
There are two processes of ciliary cargo transport. Within the axoneme, ciliary 
proteins are transported by intraflagelar transport (IFT), a bidirectional trafficking system that 
ensures the transport of ciliary cargo from the base to the tip of the cilium and backwards. 
The IFT machinery can be divided in two complexes, IFT-A (IFT144, IFT140, IFT139, and 
IFT122) and IFT-B (IFT172, IFT88, IFT81, IFT80, IFT74, IFT57, IFT52, IFT46, IFT27, and 
IFT20) (47). IFT involves movement of large protein complexes called IFT particles, or trains. 
Importantly, since cilia do not possess protein synthesis machinery, ciliary proteins have to 
be transported from intracellular compartments to cilia, using the vesicular trafficking 
pathways (1, 5, 9). 
Ciliary targeting signals (CTS) are present in the C-terminal region of ciliary 
transmembranar proteins (5). The first CTS identified was that from rhodopsin. This protein 
contains a CTS of the VxP type (QVSVPA) (1) that is also present in polycystin 2 (PKD2). 
Another common CTS motif is the AQ box, present in the third intracellular loop of GPCRs 
that localize to the cilia, like somatostatin receptor 3 (SSTR3) and 5-hydroxytryptamine 
receptor 6 (5-HTR6) (1). Interestingly, CTS motifs have been shown to integrate lipid rafts 
through post-translational modifications like myristoylation, SUMOylation and/or 
palmitoylation (1, 5, 17). Strikingly, mutations in the CTS impair the ciliary targeting and 
localization of PKD2, SSTR3 and 5-HTR6 (1, 48, 49).  
1.3.1 Intraflagellar transport 
 
Kinesin-2 motors and the IFT-B complex, ensure transport within the axoneme of 
ciliary cargo from the base to the distal tip of the cilium in an anterograde direction, to the 
plus-ends of microtubules. This transport is required for cilia assembly and correct 
localization of ciliary receptors. Dynein-2 motors and the IFT-A complex that carry turnover 
product direct the transport from the tip to the base of the cilium in a retrograde direction, to 
the minus-end. These are then transported into the cell body for recycling or degradation. 
This retrograde transport is also necessary for cilia disassembly (1, 5, 14, 50). 
1.3.2 Transport from intracellular compartments to the cilium 
 
Several models have been proposed for the routes followed by ciliary cargoes until 
they reach the cilium: polarized exocytosis of membrane proteins from the TGN directly to 
the ciliary pocket; incorporation of ciliary membrane proteins into the plasma membrane and 
movement into the ciliary membrane by lateral diffusion; and trafficking from the ERC to the 
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ciliary pocket. A schematic representation of these three models can be seen in Figure 3. It 
should be noted that these models are not mutually exclusive and that different ciliary 
cargoes could use different pathways. 
The first model proposes that vesicles from the TGN are transported to the ciliary 
pocket at the base of the cilium, where they fuse with the ciliary membrane and then enter 
the cilioplasm (1). The IFT20 protein localizes at the ciliary pocket and the Golgi apparatus 
and has been shown to be necessary for the trafficking of PKD2 to the cilium. (51). These 
findings suggest that a possible function of IFT20 is the sorting of vesicles that are destined 
for the ciliary pocket at the TGN. The vesicles are then transported along microtubules to the 
base of the cilia and fuse with the ciliary membrane (5, 51, 52).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Models for the trafficking of membrane proteins to cilia. (1) Direct trafficking from the Golgi to the 
ciliary pocket. (2) Transport to the cell surface followed by lateral transport into the cilium. (3) Internalization into 
the ERC (recycling pathway) and trafficking to the ciliary pocket. Taken from Milenkovit et al, 2009 (53). 
 
The second model of ciliary membrane protein trafficking postulates a lateral 
transport route. Studies with Smoothened (Smo), a ciliary GPCR that after Patched receptor 
activation by Hedgehog is translocated to cilia, demonstrate that upon inhibition of the 
endocityc pathway, Smo continues to be transported to cilia by lateral diffusion. This 
supports the existence of lateral transport of ciliary cargoes from the plasma membrane to 
the cilium (5, 53). However, it remains to be shown how the ciliary proteins pass the diffusion 
barrier between the plasma membrane and the ciliary membrane.  
The third model is based on polarized exocytosis, in which the proteins are 
transported in vesicles from the TGN towards the ciliary pocket and then delivered to the 
ciliary membrane by fusion. This is illustrated by Rab11-Rabin8-Rab8 ciliogenesis cascade 
(1, 5, 54). Rab8 is the last GTPase in this cascade and regulates polarized vesicular traffic 
and carrier fusion. Rab11 is essential for Rab8 activation, since it activates Rabin8, a GEF 
that favors the GDP release from Rab8, converting it to its active state (54, 55). When Rab8 
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distinguish Smo on the plasma membrane from Smo on the 
ciliary membrane, so the location of Smo was also determined by 
microscopy. We reasoned that Smo on the cell surface would be 
labeled by an antibody against an epitope on the N-terminal region 
of the protein (Fig. 2 A). When smo?/? cells producing Smo 
tagged at its N terminus with YFP (YFP-Smo cells; Rohatgi et al., 
2009) were exposed to an anti-YFP antibody, surface-exposed Smo 
could be readily detected before and after Shh addition (Fig. 2 C). 
The polyclonal anti-YFP antibody cross-linked surface YFP-Smo 
into aggregates visible over the entire plasma membrane, with-
out any evidence for enrichment in a particular plasma membrane 
domain. YFP-Smo was detected at cilia only after Shh addition 
(Fig. 2 C, right). In control experiments, anti-YFP did not label 
smo?/? cells producing Smo fused to a different tag (Fig. S1 A). 
An antibody directed against an intracellular part of Smo (anti-
SmoC; Rohatgi et al., 2007) did not label intact cells (Fig. S1 B). 
Thus, we conclude that Smo is present on the plasma membrane 
of both Shh-treated and untreated cells, which is consistent with 
the lateral transport or recycling models for transport.
If surface Smo undergoes transport into cilia, the aggrega-
tion of YFP-Smo by the anti-YFP antibody could block its 
movement to cilia, which is analogous to blocking the lateral 
diffusion of neurotransmitter receptors by antibody cross-linking 
on the surface of neurons (Ashby et al., 2006). Surfa e cross-
linking should have little effect if delivery of Smo to the cilium 
involves exocytosis from internal pools upon addition of Shh. 
Consistent with the first possibility, treatment of cells with anti-
YFP during the period of Shh exposure largely prevented trans-
port of YFP-Smo to cilia (Fig. 2 D).
localization by fluorescence microscopy, to monitor the move-
ment of the transmembrane protein Smoothened (Smo) to pri-
mary cilia. Smo, which is encoded by a human proto-oncogene, 
is a component of the Hedgehog (Hh) signal transduction path-
way. Hh signaling is a cilium-associated pathway that plays 
fundamental roles in development, stem cell f nction, and 
carcinogenesis. The binding of the ligand Sonic Hedgehog (Shh) 
to its receptor Patched 1 (Ptc1) triggers the accumulation of Smo 
within the ciliary membrane and the activation of signaling 
(Corbit et al., 2005; Rohatgi et al., 2007). Drugs targeting Smo 
are being tested in human cancer patients and some of these com-
pounds function by blocking Smo transport to cilia (Rohatgi et al., 
2009; Scales and de Sauvage, 2009). In addition to shedding 
light on the problem of ciliary protein trafficking, an under-
standing of the molecular mechanisms underlying Smo accu-
mulation in cilia will shed light into how this potentially 
oncogenic protein is activated.
Results and discussion
Smo is present on the cell surface  
and translocates to primary cilia after  
Shh stimulation
T e recycling and lateral transport pathways (F g. 1) require that 
Smo should be present on the plasma membrane of cells, which has 
been difficult to detect by simple fluorescence (Rohatgi et al., 
2007). Using non–cell-permeable biotinylation, endogenous 
Smo could be readily detected on the surface of NIH3T3 cells 
(Fig. 2 B) before and after Shh addition. This assay cannot 
Figure 1. Three models for Hh-induced Smo 
transport to the primary cilium. (1) Direct traf-
ficking from the Golgi to the base of the cilium. 
(2) Transport to the cell surface followed by 
lateral transport into the cilium. (3) Surface 
localization followed by internalization into a 
recycling pathway.
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is active, it directly interacts with ciliary cargoes like Rhodopsin, Polycystin-1 (PKD1) and 
Fibrocystin promoting the docking and fusion of vesicles to the ciliary membrane (24, 54, 56). 
The need for vesicular trafficking pathways in cilia assembly and maintenance 
suggests an important role for this type of transport in cilia biology. Indeed, defects in these 
pathways affect the correct formation and function of this organelle, leading to several 
diseases collectively known as ciliopathies. 
1.4 Ciliopathies 
 
Ciliopathies are a broad and heterogeneous group of diseases that affect several 
organs and systems and are caused by defects in cilia. This group of diseases includes 
autosomal dominant polycystic kidney disease (ADPKD), Bardet-Biedl syndrome (BBS), 
Joubert syndrome (JBTS), Nephronophtisis (NPHP), and Meckel-Gruber syndrome (MKS), 
among others. More than 50 genes are known to be involved. Interestingly, different 
mutations in the same gene can cause different diseases with pleiotropic phenotypes and 
several ciliophaties are caused by mutations in different genes (2, 40, 49, 57). 
1.4.1 Joubert syndrome 
 
Joubert syndrome (JBTS) is an autosomal recessive ciliopathy characterized by 
retinal dystrophy, cystic renal disease, polydactyly, hindbrain malformation, known as the 
‘molar tooth sign’, along with ataxia and cognitive dysfunction. Furthermore, the genes 
affected in JBTS are all required for ciliogenesis. Consequently, mutations in these genes 
lead to the absence or shorter primary cilia, as well as impaired ciliary motility (37, 49, 57). 
One of the genes associated with JBTS is ARL13B. Indeed, two missense mutations 
in ARL13B were linked to JBTS, R79Q, localized in the Arf-domain and R200C, localized in 
the coiled-coil motif. R79 is speculated to be critical for establishing the proper GTP-bound 
conformation of Arl13b that is required for effector binding. R200C mutation is thought to 
destabilize the position of the helix α6 of the coiled-coil region relative to the Arf-domain, 
suggesting that a fixed orientation of the coiled-coil region is crucial for correct Arl13b 
function (43). 
Recently, a mutation in one of the exocyst complex subunits, Exo84 was found to 
cause JBTS in human families (58). The exocyst is a multi-subunit complex consisting of 
eight proteins, Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84. This complex is 
thought to be essential for polarized exocytosis and to mediate the tethering of secretory 
vesicles to the plasma membrane before SNARE-mediated fusion (18, 59, 60). Interestingly, 
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the exocyst was found to localize to the primary cilium and to be essential for ciliogenesis 
(60). Moreover, it is a downstream effector of Rab8 and Rab11 (54). 
Since mutations in both Arl13b and a subunit of the exocyst were found in patients 
with JBTS and both are involved in ciliary cargo trafficking, it is possible that an interaction 
between the exocyst and Arl13b occurs in ciliogenesis. 
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2 Hypothesis and objectives 
 
 We hypothesize that Arl13b regulates ciliary cargo trafficking from compartments of 
the endocytic recycling pathway to the cilium through an interaction with the exocyst 
complex, thereby controlling cilia biogenesis and function. Therefore, the specific aims of this 
work were: 
 
Aim 1: To confirm and characterize the interaction between Arl13b and the exocyst in 
ciliated cell lines. 
 
Aim 2: To assess the function of the interaction between Arl13b and the exocyst in 
ciliogenesis. 
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3 Materials and Methods 
3.1 Cell Culture 
 
All cell lines used in this worked were cultured at 37ºC with 5% CO2. Hela and MDCK 
cell lines were grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen) 
supplemented with 10% heated-inactivated fetal bovine serum (FBS, Invitrogen), 100 U/ml 
penicillin G, 100 µg/ml streptomycin, 2mM L-glutamine and 20mM Hepes (Invitrogen). NIH-
3T3 cells were grown in the same conditions but supplemented with 10% heated-inactivated 
bovine calf serum (BCS, Sigma). IMCD3 cells were grown in Dulbecco’s Modified Eagle 
Medium/Nutrient Mixture F-12 (DMEM/F-12, Invitrogen) supplemented with 10% heated-
inactivated FBS (GIBCO), 100 U/ml penicillin G and 100 µg/ml streptomycin (Invitrogen). To 
induce cilia formation, IMCD3 cells were serum-starved for 48h and NIH-3T3 cells were 
starved for 24h. 
Cell lines were lysed in cold lysis buffer (50 mM Tris-HCl pH 7,5, 10% Igepal, 150 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 2 mM MgCl2, 1 mM DTT), in the presence of protease and 
phosphatase inhibitors, for 30 minutes at 4ºC with constant agitation followed by 
centrifugation at 20000 g for 30 minutes at 4ºC. Supernatants were collected and protein 
concentration was determined using DC protein assay kit (Bio-Rad). 
3.2 Silencing assays 
 
Arl13b and Sec8 silencing was achived using siGENOME SMARTpool (Thermo 
Scientific) specific for Mus musculus Arl13b and Sec8. Control siRNA was done with non-
targeting siRNA pool (Thermo Scientific). NIH-3T3 cells were transfected with 80 nM siRNA 
with Dharmafect 1 transfection reagent (Thermo Scientific) according to the manufacturer’s 
instructions. NIH-3T3 cells were serum-starved after 48h of transfection with siRNA for 16h 
prior to fixation or pellets collection. 
The target sequences used for Arl13b siRNA were; CUAAGACACCCGAGGAUAU, 
GAAUUAUUAUGCUGAAUCC, GAAACAAAGGAGACAAUGU and 
GGUAAUAUUUGUUGUGGAU, for Sec8 siRNA the following sequences were used; 
UCACUAACUCGAGGAAUAA, GGGCAAAGGAUGAUGAUAU, 
CGUCAUAUUCCAUCCAUUA and CAACUAAGCUAUGCCAGUA. 
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3.3 Plasmid transfection and constructs 
 
The following plasmids were used: pEGFP-C-CMV5 Arl13b construct was a kind gift 
from Dr. K. Kontani (University of Tokyo, Japan). Arl13b 1-193-EGFP mutant and Arl13b-
FLAG constructs were described previously (22). pGBKT7-Sec8-Myc construct was a kind 
gift from Dr. Joshua Lipschutz (University of Pennsylvania, United States of America). Arl13b 
[194-428]-EGFP was generated by removing Arl13b from the vector pEGFP-C-CMV5 Arl13b 
and replacing it by Arl13b [194-428] by A. Portelinha and D. Barral  (unpublished). 
Plasmid transfections were done using Turbofect (ThermoScientific) in HeLa and NIH-
3T3 or with Lipofectamine 2000 (Invitrogen) in IMCD3 cells, according to the manufacturer’s 
instructions. 
3.4 In vitro protein translation 
 
Proteins were produced using TnT® T7 coupled reticulocyte lysate system (Promega) 
by mixing 40 µl of TnT® T7 Quick Master Mix with 1 µl of Methionine at 1 mM, 2 µg of 
plasmid DNA template and nuclease-free water to a final volume of 50 µl. The mixture was 
incubated at 25ºC for 90 minutes to synthesize in vitro the proteins from the plasmid DNA 
template. 
3.5 Immunoprecitation 
 
For immunoprecipitation, cell lysates were pre-cleared for 1 hour with Protein G-
Sepharose beads (Sigma). Samples were then incubated with GTPγS (0,5 mM, Sigma) or 
GDP (5 mM, Sigma) for 10 minutes at room temperature (RT). Immunoprecipitation was 
performed overnight at 4ºC with constant agitation, using 3 µg of anti-Arl13b (Barral et al, 
2012), 2 µg of anti-Sec8 (Enzo life Science), 2 µg of anti-Myc (Calbiochem) or 2 µg of anti-
FLAG (Sigma). ProteinG-Sepharose beads were then added and mixed for 4 hours at 4ºC 
with rotation. Beads were recovered by centrifugation at 20000 g for 5 minutes at 4ºC, 
washed once with lysis buffer with high salt concentration (500 mM NaCl), three times with 
lysis buffer, and finally resuspended in Laemmli sample buffer. After boiling at 94ºC for 5 
minutes, the immunoprecipitates were resolved by SDS-PAGE followed by immunoblotting. 
3.6 GFP-pull-down 
 
To pull down Arl13b-EGFP, GFP-trap beads (Chromotek) were used with 800 µg of 
HeLa total cell lysates overexpressing the different constructs (Arl13b-EGFP, Arl13b [1-193]-
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EGFP and Arl13b [194-428]-EGFP). Samples were incubated with GTPγS (0,5 mM, Sigma) 
or GDP (5 mM, Sigma) for 10 minutes at RT. Immunoprecipitations were performed at 4ºC 
for 2 hours with constant mixing. Beads were then recovered by centrifugation at 2500 g for 3 
minutes at 4ºC, washed once with lysis buffer with high salt concentration (500 mM NaCl), 
three times with lysis buffer, and finally resuspended in Laemmli sample buffer. After boiling 
at 94ºC for 5 minutes, the immunoprecipitates were resolved by SDS-PAGE followed by 
immunoblotting. Alternatively, instead of directly resuspended the beads, they were eluted 
with 0,2 M glycine pH 2,5 for 30 seconds under constant mixing at RT, followed by 
centrifugation, and then neutralized with 1 M Tris HCl pH 10.4. This step was repeated twice 
to increase the elution efficiency. After elution, samples were dialysed in lysis buffer without 
protease and phosphatase inhibitors, under constant mixing at 4ºC overnight with Snakeskin 
dialysis membrane with a cut-off of 10 kDa molecular weight (Thermo Scientific). The buffer 
was replaced once and dialysis proceeded in the same conditions for 4 hours. Dialyzed 
samples were then resolved by SDS-PAGE followed by immunoblotting. 
3.7 Immunobloting 
 
Samples were resolved by SDS-PAGE and transferred onto nitrocellulose membranes 
in transfer buffer (25 mM Tris; 192 mM glycine; 0,5% SDS; 20% Methanol) for 90 minutes at 
500 mA and processed for immunoblotting. Membranes were blocked with blocking buffer 
(5% skimmed milk and PBS with 0.1% Tween-20) and the antibodies incubated in the 
blocking buffer. Anti-Arl13b (Barral et al., 2012) was used at 0.6 µg/ml, anti-GAPDH 
(Glyceraldehyde-3-phosphate dehydrogenase, SicGen) at 0.2 µg/ml, anti-Sec8 (Enzo life 
Science) at 0.2 µg/ml, anti-GFP (Sicgen) at 0.2 µg/ml, anti-FLAG (Sigma) at 0.7 µg/ml, anti-
Myc (Calbiochem) at 0.1 µg/ml, anti-Exo70 (Milipore) at 0.1 µg/ml and HRP-conjugated 
secondary antibodies (GE Healthcare) were used at 0.7 µg/ml. Blots were developed with 
ClarityTM Western ECL substrate (Bio-Rad) or Amersham ECL Prime (GE Healthcare) 
according to the manufacturer’s instructions and a Molecular Imager Chemidoc XRS (Bio-
Rad) was used to detect the chemiluminescence. Band intensities were quantified using 
ImageJ software and normalized using GAPDH or GFP. 
3.8 Immunofluorescence 
 
Cells grown on glass coverslips were serum-starved for 24 (NIH-3T3) or 48 hours 
(IMCD3), washed with PBS and fixed in 4% paraformaldehyde in PBS for 15-20 minutes at 
RT. Then coverslips were permeabilized and block with PBS, 0.5% BSA and 0.1% saponin 
for 15 minutes at RT. Next slices were incubated for 1 hour at RT with primary antibody such 
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as anti-Arl13b antibody (kind gift from Tamara Caspary, Emory University, USA) and anti-
acetylated tubulin (Sigma). The slides were then washed five times with PBS, 0.5% BSA and 
0.1% saponin. Secondary Alexa fluor 488- or 568-conjugated anti-rabbit or anti-mouse 
antibodies (Invitrogen) were incubated in the PBS, 0.5% BSA and 0.1% saponin for 1 hour at 
RT and washed once and the nuclei were stained with DAPI in the same buffer for 10 
minutes at RT. After washing three more times coverslips were mounted in mounting 
medium (15% w/v vinol 205, 33% v/v glycerol, PBS in 0.1% azide) and analyzed in a Zeiss 
LSM 710 confocal microscope equipped with a Plan-Apochromat 63/1.40 Oil Ph3 lens and 
Zeiss Zen 2010 software. Images were processed with ImageJ software adjusting the levels 
or brightness of each channel up to a maximum threshold defined by the absence of signal in 
the negative controls stained with irrelevant IgG antibodies. 
3.9 RNA extraction, complementary DNA production and real-time 
quantitative PCR 
 
RNA from cells lysates was extracted with RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. One µg of total RNA was reverse-transcribed to synthesize 
complementary DNA (cDNA). Samples were incubated with 10 mM dNTPs mix (Thermo 
Scientific) and random primers (Sigma) at 65ºC for 5 minutes. Samples were then incubated 
with 5x buffer (Invitrogen), DTT (Invitrogen) and RNAseOUT (Invitrogen) at 25ºC for 5 
minutes, and finally incubated with Superscript II (Invitrogen) first at 25ºC for 10 minutes, 
then at 42ºC for 50 minutes and finally at 70ºC for 15 minutes. For the real-time quantitative 
PCR (qRT-PCR), Brilliant SYBR® Green QPCR Master Mix (Roche) was used according to 
the manufacturer’s instructions and the analysis was done in a qPCR Roche Lyghtcycler 
(Roche).  
The primers used were 5’-GAATCCAAGGAGAATACCCTG-3’ (forward) and 5’-
CCAACACCAATATAGGCTTTCC-3’ (reverse), for Arl13b, 5’-
GGAAATACAGGAGCACAGTCAG-3’ (forward) and 5’-CACGGTCACACTTCTCATAGG-3’ 
(reverse), for Sec8, 5’-CATTTCCTGGTATGACAACGA-3’ (forward) and 5’-
GTCTACATGGCAACTGTGAG-3’ (reverse), for GAPDH used to normalize the values of 
expression. 
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4 Results 
Cecília Seixas performed Figure 4A, 4C and Supplementary Figure 1 and I performed 
all the remaining work with her assistance. 
4.1 Characterization of the interaction between Arl13b and the exocyst 
complex 
 
Several small G proteins belonging to the Rho, Rab, and Arf families interact with 
exocyst subunits to regulate the function of this complex (61–64). Moreover, mutations in the 
exocyst subunits or Arl13b cause Joubert syndrome in human families (58), suggesting a link 
between the exocyst and Arl13b. Since Sec8 is present in cilia (60, 65–67), we investigated 
the existence of an interaction between the exocyst complex and Arl13b through Sec8 
subunit. 
4.1.1 Sec8 is an Arl13b effector 
 
We tested if there is an interaction between Arl13b and Sec8, by 
immunoprecipitations. A specific Arl13b antibody was used to capture Arl13b from total 
lysates of mouse inner medullary collecting duct (IMCD3) cells and, immunoprecipitates were 
probed for the presence of Sec8 by immunoblot (Fig. 4).  
Since small G proteins preferentially bind effectors in their GTP-bound, active state, 
we incubated cell lysates with GTPγS, a non-hydrolyzable form of GTP, or GDP, as a control, 
prior to performing the immunoprecipitations, as described in Materials and Methods. We 
found that the pre-incubation with GTPγS dramatically increases the co-immunoprecipitation 
of Sec8 with Arl13b when compared to the pre-incubation with GDP (Fig. 4A). We regularly 
observed lower levels of non-specific Sec8 binding to the beads (e.g., see Fig. 4A, IgG lane). 
Moreover, we used the reverse strategy, i.e. we immunoprecipitated Sec8 from total cell 
lysates of ciliated IMCD3 cells and probed for Arl13b by immunoblotting (Fig. 4D). We 
observed again a GTP-dependence for the interaction between Arl13b and Sec8. These data 
are consistent with our hypothesis of Sec8 exocyst subunit serving as an effector of Arl13b. 
 To show that this interaction was not restricted to IMCD3 cell line, we also tested 
ciliated mouse embryonic fibroblasts (NIH-3T3) and Madin-Darby canine kidney (MDCK) 
cells. The results confirmed that Sec8 preferentially co-immunoprecipitates with active Arl13b 
independent of the cell line used (Fig.4B and C). Furthermore, we also immunoprecipitated 
Arl13b from non-ciliated HeLa cells and found that Sec8 also interacts with Arl13b in this cell 
line, showing that this interaction is conserved and not dependent upon the presence of cilia 
(Supplementary Fig. 1). 
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Figure 4 – Sec8 and Arl13b co-immunoprecipitation in total cell lysates of ciliated and non-ciliated cells. 
Total cell extracts were prepared and used for co-immunoprecipitation. Immunoprecipitates were resolved by 
SDS-PAGE. (A) IMCD3 cells (600 µg protein) after pre-incubating with no nucleotide (left lane), GTPγS (0,5 mM; 
2nd lane), GDP (5 mM, 3rd lane) or a non-specific rabbit IgG, as control (4th lane), samples were 
immunoprecipitated with Arl13 follow by immunoblotting with anti-Sec8 antibody. (B) MDCK cells prepared as 
described in (A). (C) NIH-3T3 cells prepared as described in (A). (D) IMCD3 cells (600 µg protein) 
immunoprecipitated with Sec8 or a non-specific IgG, as control, follow by immunoblotting with anti-Arl13b 
antibody. Asterisks (*) indicate the denatured heavy chains, absent in the cell lysate (input).  
4.1.2 Sec8 and Arl13b interact directly 
 
 Since Sec8 belongs to a multi-subunit complex, the exocyst, we asked if Arl13b 
interacts directly with this subunit. For that, Sec8-Myc and Arl13b-FLAG were separately 
translated in vitro by a transcription and translation (TNT) T7 polymerase-coupled 
reticulocyte lysate system using plasmids encoding the C-terminal tagged proteins as 
templates. The reliability of this system to generate the tagged proteins in vitro was 
confirmed by immunoblotting (Fig. 5A). The synthesized proteins were then mixed and 
incubated in the presence of GTPγS. Immunoprecipitation was performed with anti-FLAG 
monoclonal antibody and the immunoprecipitated products were analyzed by immunoblot 
with anti-Myc antibody. We observed that the in vitro-translated Sec8-Myc co-precipitates 
with Arl13b-FLAG, suggesting that these two proteins interact directly (Fig. 5B, lane 1, 
asterisk). As an internal control, we performed the immunoprecipitation with an irrelevant 
IgG. In this case, we detected a faint band by immunoblotting with anti-Myc antibody that 
corresponds to the Sec8-Myc that bound to the beads non-specifically (Fig. 5B, lane 2). This 
band is noticeably fainter than the one co-immunoprecipitated with Arl13b-FLAG and 
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represents non-specific stickiness of Sec8 to the beads, as described. Additionally, we 
performed an immunoprecipitation with anti-FLAG antibody using as input a mixture of in 
vitro-translated Arl13b-FLAG with a TNT reaction in which no DNA was added as template. 
As expected, we failed to detect a band by immunoblotting with the anti-Myc antibody (Fig. 
5B, lane 3).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 – Sec8 and Arl13b interact directly. (A) Sec8-Myc and Arl13b-FLAG were in vitro-translated using the 
transcription and translation (TNT) T7 coupled reticulocyte lysate system. Five percent of the input was resolved 
by SDS-PAGE and analyzed by immunoblotting with anti-Sec8, anti-Myc, anti-Arl13b or anti-FLAG antibodies. As 
a control, a TNT reaction without DNA as template was analyzed to distinguish the endogenous levels of the 
proteins in the reticulocyte lysates from the in vitro-translated proteins. (B) Immunoprecipitation with anti-FLAG 
antibody was performed using as input a mixture of the in vitro-translated proteins, in the presence of GTPγS. 
Immunoprecipitates (lane 1) were analyzed by immunoblot with anti-Myc, anti-Sec8 or anti-FLAG antibodies. As a 
negative control, immunoprecipitations were performed with an irrelevant mouse IgG1 (IgG) (lane 2), or with an 
anti-FLAG antibody using as input a TNT reaction with no DNA as template that was mixed, in the presence of 
GTPγS, with in vitro-translated Arl13b-FLAG (lane 3). Asterisks (*) indicate in vitro-translated Sec8-Myc and the 
pound (#) signs indicate endogenous Sec8.  
 
Thus, our data clearly demonstrates that Sec8 does not need to be present in the 
exocyst complex in order to be co-immunoprecipitated with Arl13b, and supports a direct 
interaction between Arl13b and Sec8. 
4.1.3 Exo70 co-immunoprecipitates with Arl13b 
 
Since we have demonstrated that Sec8 directly binds to Arl13b, we wondered if other 
subunits of the exocyst were also co-immunprecipitated with Arl13b in ciliated cell lines. To 
assess this, we performed an immunoprecipitation assay in MDCK and NIH-3T3 cells. For 
this, total MDCK cell lysate was pre-incubated with GTPγS and then incubated with anti-
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Arl13b antibody, or an irrelevant IgG as a negative control. The immunoprecipitates were 
then analyzed by immunoblot using anti-Exo70 antibody (Figure 6A). We observed a band 
with the expected molecular weight for Exo70 in the lane where the product of 
immunoprecipitation with Arl13b was separated, suggesting that Exo70 co-
immunoprecipitates with Arl13b. We also tested the interaction between Arl13b and Exo70 in 
NIH-3T3 cells (Figure 6B). For this, total NIH-3T3 cell lysates were pre-incubated with 
GTPγS or GDP and then incubated with anti-Arl13b antibody. The immunoprecipitates were 
then analyzed by immunoblot using anti-Exo70 antibody. In this case we obtain a similar 
results since Exo70 is co-immunoprecipitated with Arl13b also in this cell line. Moreover, we 
found that the pre-incubation step with GTPγS dramatically increases the co-
immunoprecipitation of Exo70 with Arl13b when compared to the pre-incubated with GDP. 
Hence, this result suggests that Arl13b interacts with the whole exocyst complex. 
 
 
 
 
 
 
 
 
 
Figure 6 – Exo70 co-Immunoprecipitates with Arl13b in MDCK and NIH-3T3 cells. (A) Total cell lysates from 
MDCK cells (800 µg protein) were immunoprecipitated with anti-Arl13b antibody after pre-incubation with GTPγS 
(0,5 mM; left lane), or with a non-specific rabbit IgG as a control, also pre-incubated with GTPγS (0,5 mM; right 
lane). (B) Total cell lysates from NIH-3T3 cells (800 µg protein) were immunoprecipitated with anti-Arl13b 
antibody after pre-incubation with GTPγS (0,5 mM; left lane), or GDP (5 mM; right lane). Immunoprecipitates were 
resolved by SDS-PAGE followed by immunoblotting with anti-Exo70 antibody for both (A) and (B). 
4.1.4 Sec8 and Arl13b interaction is abolished by Arl13b N- or C-terminal 
domain truncation 
 
In order to characterize Arl13b-Sec8 interaction, we investigated the Arl13b domains 
responsible for this interaction testing by immunoprecipitation with the same system used 
previously which Arl13b domain interacts with Sec8. With this goal in mind, we 
overexpressed three forms of Arl13b tagged with GFP: a full-length Arl13b form, and two 
truncation mutants, Arl13b [1-193] and Arl13b [194-428]. The mutant Arl13b [1-193] contains 
only the Arf domain of the protein and the mutant Arl13b [194-428] contains the coiled-coil 
domain and the proline-rich regions (Supplementary Figure 2). 
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After overexpressing the different forms of Arl13b we confirmed the transfection 
efficiency by fluorescence microscopy. The percentage of transfection was similar for all 
Arl13b constructs. We analysed total cell lysate from the transfected cells by SDS-PAGE 
followed by immunoblot with anti-GFP antibody. The intensity of the bands corresponding to 
the different forms of tagged Arl13b were different, suggesting that the levels of expression of 
the different Arl13b forms were distinct, despite the percentage of transfection being similar 
(Fig. 7A). Therefore, to ensure that the same amount of each Arl13b construct was used in 
the immunoprecipitation, the levels of GFP-tagged Arl13b were first normalized to GAPDH 
and then relative to each other. However, to use similar amounts of the different Arl13b 
mutant proteins, the volume of cell lysate had to be different between samples, which implied 
also a different amount of binding partners. 
 
 
 
 
 
 
 
 
 
 
Figure 7 – Arl13b-GFP pull-downs. (A) Cell lysates from HeLa cells (80 µg protein) overexpressing Arl13b-GFP 
full length, Arl13b[1-193]-GFP or Arl13b[194-428]-GFP were resolved by SDS-PAGE and immunoblotted with 
anti-GFP antibody. (B) Cell lysates from HeLa cells (800 µg protein) overexpressing Arl13b-GFP full length, 
Arl13b[1-193]-GFP or Arl13b[194-428]-GFP were immunoprecipitated with GFP-trap beads to pull-down Arl13b 
proteins tagged with GFP. Asterisks (*) indicate the band for each construct. 
 
To overcome this problem, we performed a pull-down of GFP-tagged proteins using 
GFP-trap beads instead of ProteinG-beads used previously. This allows the 
immunoprecipitation of GFP-tagged proteins as well as their binding partners. Since the 
beads can be saturated with Arl13b-GFP, it also allows the normalization of the levels of 
GFP-Arl13b mutants and binding partners. Importantly, we observed that the 
immunoprecipitation with the GFP-trap beads pulled-down similar levels of the three 
constructs (Supplementary Figure 3). We incubated total HeLa cell lysates overexpressing 
each construct with the GFP-trap beads in the presence of GTPγS, GDP, or no nucleotide. 
As a negative control, we used HeLa cell lysates overexpressing a construct encoding GFP 
in the presence of GTPγS. The immunoprecipitated products were analyzed by immunoblot 
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with Sec8 or Exo70 antibody. The results show that Sec8 and Exo70 are co-
immunoprecipitated in the presence of the full-length Arl13b and GTPγS (Fig. 8A). As 
expected, in the presence of GDP, both Sec8 and Exo70 are immunoprecipitated at a lower 
level when compared with the samples incubated with GTPγS. The intensity of the band for 
Sec8 and Exo70 detected in the immunoblots was then normalized to the GFP band intensity 
for each Arl13b form. Regarding the mutants, both show impaired binding to Sec8 and Exo70 
in the presence of GTPγS (Fig. 8B and 8C). This result suggests that both domains of Arl13b 
are required for the interaction with Sec8 and Exo70. We also observed an interaction above 
the background level with Sec8 and Exo70 with the mutant Arl13b [1-193]. However, it 
cannot be considered a biologically relevant interaction since it is significantly lower than the 
interaction observed with the full length Arl13b in the presence of GDP. Thus, from this 
experiment we can only conclude that none of the truncated Arl13b mutants can interact with 
Sec8 or Exo70, since the intensity of the corresponding bands is similar to the negative 
control done with cell lysates overexpressing GFP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 – Characterization of Sec8 interaction with Arl13b truncation mutants in the presence of GTPγS, 
GDP or no nucleotide. (A) Total lysates from HeLa cells overexpressing Arl13b-GFP full-length, Arl13b[1-193]-
GFP or Arl13b[194-428] were immunoprecipitated from total cell lysates (800 µg protein) with GFP-trap beads, 
after pre-incubation with GTPγS (0,5 mM), GDP (5 mM) or no nucleotide. As a negative control we used total cell 
lysates from HeLa cells overexpressing GFP pre-incubated with GTPγS (0,5 mM) to set the background level of 
unspecific binding of Sec8 to the beads. Immunoprecipitates were resolved by SDS-PAGE, followed by 
immunoblotting with anti-Sec8 and anti-Exo70 antibodies. (B) Quantification of the bands intensities for Sec8 
shown in (A), using ImageJ software and normalized for GFP levels. (C) Quantification of the bands intensities for 
Exo70 shown in (A), using ImageJ software and normalized for GFP levels. 
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4.2 Function of Arl13b-exocyst complex in ciliogenesis 
 
Defects in ciliogenesis have been implicated in several cilopathies. Arl13b is a ciliary 
protein known to be involved in cilia formation/maintenance and signalling and is recognized 
as a central protein in ciliogenesis (15, 46). Besides that, the exocyst, namely the Sec10 
subunit, has been demonstrated to also play a crucial role in ciliogenesis (18, 59). Therefore, 
since Arl13b and the exocyst are known to be ciliogenesis regulators and we found that both 
interact through the Sec8 subunit, we assessed if Sec8 silencing could mimic the phenotypes 
obtained when silencing Arl13b. If that was the case, it would further suggest that Arl13b and 
exocyst work in the same pathway in ciliogenesis. 
4.2.1 Arl13b and Sec8 depletion affect cilia formation and length in NIH-3T3 
cells 
 
To assess if Arl13b or Sec8 depletion cause defects in cilia formation, we silenced 
Arl13b or Sec8 using (Small interfering RNA) siRNA pools in NIH-3T3 cells and measured 
the silencing levels by qRT-PCR. Silencing of 75% and 76% were obtained for Arl13b and 
Sec8, respectively (Supplementary Figure 4). We then measured the length of cilia in cells 
treated with siControl, siArl13b or siSec8 (Figure 9). 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – Defects in ciliogenesis upon depletion of Arl13b and Sec8. Normalized histogram showing the 
cilia length measured in NIH-3T3 cells transfected with siRNA pools to silence Sec8 and Arl13b. A pool of siRNA 
control was used as control. 
 
In cells treated with siControl, the average cilia length was 2,5 µm and they fail to 
grow cilia longer then 5,5 µm, while in cells treated with siArl13b the average length was 1,5 
µm and cells fail to grow cilia longer than 4 µm. This reduction in cilia length and delay in 
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ciliogenesis was expected since Arl13b is known to be required for cilia biogenesis and 
maintenance (15, 46). The cells treated with siSec8 showed an average cilia length of 2 µm. 
Furthermore, an abrogation in ciliogenesis could be perceived in these cells since they fail to 
grow cilia longer than 5 µm and at the same time display more cilia shorter than 0,5 µm than 
cells treated with siControl suggesting that Sec8 is required for proper ciliogenesis.  
 This result suggests that Arl13b and exocyst are in the same pathway since silencing 
of Arl13b and Sec8 cause similar defects in ciliogenesis. However the defects caused in 
absence of Arl13b are stronger than the ones observed when silencing Sec8, indicating that 
the cell could have a compensatory mechanism to assist in ciliogenesis in the absence of the 
exocyst but not in the absence of Arl13b. 
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5 Discussion and future perspectives 
 
Mutations in Arl13b and the exocyst subunity Exo84 have been found in human 
patients with Joubert syndrome (JBTS) (49, 58). Arl13b was described as a ciliary protein 
whose depletion leads to defects in cilia structure and function (15, 42, 46). The exocyst is a 
hetero-octomeric complex best known for its function in tethering exocytic vesicles to the 
plasma membrane. Moreover, it has recently been associated with ciliogenesis and in vesicle 
trafficking to the apical membrane (59, 60).  
Regarding our first aim, we show for the first time that Sec8 is a bona fide effector of 
Arl13b, since Arl13b co-immunoprecipitation with Sec8 is considerably increased in the 
presence of GTPγS. We also show that this interaction is present in different cell types and 
that it is not dependent upon the presence of cilia. Moreover, we found that this interaction is 
direct and independent of the presence of the other exocyst subunits since in vitro-translated 
Sec8-Myc co-immunoprecipitates with Arl13b-FLAG. Furthermore, this result suggests that 
Sec8 does not need to be present in the exocyst complex to interact with Arl13b.  
Importantly, we found that both the N- and C-terminal domains of Arl13b are 
necessary for the interaction with Sec8. In order to characterize the interaction between 
Arl13b and Sec8 and to know the Arl13b domains responsible for the interaction, we 
performed an immunoprecipitation with GFP-trap beads, which allows the concentration of 
the GFP-tagged proteins expressed from the constructs of three different forms of Arl13b. 
Using this method, we confirmed that Sec8 is an Arl13b effector and that the binding to Sec8 
requires both the N- and C- terminal domains of Arl13b. A possible explanation for the lack of 
the interaction in the mutant Arl13b [1-193] is that the C-terminal domain of Arl13b has an 
important role in the stabilization of the protein to allow the molecular conversion of GTP into 
GDP in the Arf domain, controlling the binding of effectors to the protein (43). Thus, the lack 
of the C-terminal domain of Arl13b would impair the GTP binding to the Arf domain and 
consequently the exchange from the inactive to the active state. The mutant Arl13b [194-428] 
does not have the Arf domain, so it has no manner of binding to GTP and exchange to the 
active state. Since Arl13b binds to the effector Sec8 when in the active state and this mutant 
fail to exchange states it was expected that the interaction fail to occur. To investigate the 
exact domain of Arl13b required for the interaction, new mutants need to be generated with 
shorter truncations and point mutations, so the protein conformation and stability is not 
dramatically affected and we can narrow down the amino acids necessary for the interaction 
to occur. 
Furthermore, Exo70 is also co-immunoprecipitated with Arl13b, suggesting that 
Arl13b could interact with the whole exocyst complex. Since only the exocyst subunits Sec10 
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and Sec15 have free pools in the cell, forming a subcomplex in addition to their incorporation 
into the exocyst complex (68), it can be speculated that the interaction of Arl13b with Sec8 
mediates the interaction with the whole complex. We also showed that Exo70 co-
immunoprecipitates with Arl13b, both in ciliated and non-ciliated cell lines. This result 
supports the hypothesis that Sec8 mediates the interaction between Arl13b and the rest of 
the exocyst complex. Thus, to demonstrate that Arl13b-Sec8 interaction occurs in the 
presence of the whole exocyst complex, it will be important to investigate if the other exocyst 
complex subunits co-immunoprecipitate with Arl13b.  
Interestingly, the transport, sorting and fusion of vesicles that transport polycystin-1 
(PKD1) to cilia, requires the participation of more than one subunit of the BBSome complex, 
a complex comprise by seven proteins BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9 
involved in intracellular trafficking (69) and mutated in Bardet-biedl syndrome (BBS). While 
BBS3/Arl6 is responsible for the ciliary trafficking of PKD1 to the ciliary base, BBS1 is 
responsible for the entry of PKD1 in cilia. This is also the case of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptors (70), in which Sec8 sorts and transports 
the AMPA receptor to neuronal axon and Exo70 assists in the fusion of the vesicles carrying 
AMPA receptors with the target membrane. Therefore, a similar model of action can be 
hypothesized for Arl13b-containing vesicles, where these vesicles follow a two-step process 
to enter cilia: first they are targeted to the periciliary region and then transported into the cilia 
in an exocyst-dependent manner. To test this hypothesis, it will be necessary to co-localize 
Arl13b, Sec8 and Exo70 and assess how depletion of Sec8 and/or Exo70 affects the 
trafficking of Arl13b to cilia. If Exo70 is responsible for the fusion of Arl13b-containing 
vesicles to the plasma membrane, when Exo70 is depleted, an accumulation of Arl13b-
containing vesicles in the periciliary region is expected. Moreover, Arl13b will fail to enter 
cilia. On the other hand, when Sec8 is silenced, an accumulation of Arl13b-containing 
vesicles will be expected in intracellular compartments such as the endocytic recycling 
compartment (ERC) since our group found that Arl13b regulates endocytic recycling traffic 
(22). Of note, several studies suggest that the ERC can serve as a donor compartment for 
ciliary cargo (1, 24). But a direct link between the role of Arl13b in endocytic recycling and its 
function in ciliogenesis has not yet been established. Therefore, it can be speculated that the 
traffic of ciliary cargo to the periciliary region is dependent on the exocyst-Arl13b complex 
and follows the endocytic recycling pathway through the ERC. To assess if there is a direct 
link between Arl13b and the endocytic recycling pathway in ciliogenesis, 
immunofluorescence studies with specific markers should be performed. For this, IMCD3 
cells can be stained with anti-acetylated tubulin to mark cilia, anti-Rab11 antibody to label the 
ERC and anti-EEA-1 antibody to mark early endosomes. If Arl13b and Sec8 co-localize with 
these markers, it will be possible to show which intracellular trafficking pathway Arl13b-
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containing vesicles are following and if the interaction between Arl13b and exocyst occurs 
just in the periciliary region or in an intracellular compartment to sort the vesicles to the ciliary 
pocket. 
Therefore, in our second aim using siRNA for silencing, we observed that Sec8 and 
Arl13b are both necessary for cilia formation. When we silence Arl13b in NIH-3T3 cells, we 
observe a reduction in cilia length, being the cells unable to grow cilia longer than 4 µm and 
an average length of 1,5 µm while in the cells treated with siControl the cilia grow until 5,5 
µm and the average length is 3 µm. This results was expected since Arl13b is known to have 
a role in ciliary formation and maintenance (15). Interestingly, we also observed an 
abrogation in ciliogenesis in cells silenced for Sec8. In this case, the cells fail to grow cilia 
longer than 5 µm and the average length is 2 µm. Importantly, we observed that there is an 
increase in the number of cilia that are shorter than 0,5 µm in cells silenced for Sec8 and 
Arl13b, suggesting that some cells cannot extend their axoneme when depleted for both 
Arl13b and Sec8. In contrast, others report that Sec8 silencing does not affect cilia formation 
(59). But those authors did not rule out the possibility that the lack of a phenotype was due to 
insufficient silencing of the protein. More studies need to be done to fully understand how 
Sec8 depletion affects ciliogenesis. It will also be necessary to look at the intracellular 
localization of Arl13b when cells are depleted to Sec8 and the other way around, to know if 
the proteins are failing to enter the cilia and if that is one possible explanation for the 
observation of shorter cilia observed by us in cells depleted for Sec8. Since exocyst is 
required for ciliogenesis and given the importance of Arl13b for formation and function, our 
findings could be extended to which ciliary proteins depend on Arl13b-exocyst regulation to 
reach the cilia, to allow understanding the etiology of JBTS. For this, it should be done 
assays in live cells expressing ciliary cargos regulated by Arl13b or by exocyst such as 
fluorescence recovery after photobleaching (FRAP) assays. This technique, as the name 
suggests, consists in photobleaching the fluorescent protein with a laser until the 
fluorescence is partially or completely lost. Then, the time of fluorescence recovery is 
monitored, giving information about the time that the protein takes to be transported from 
intracellular compartments and whether it is being imported to or exported from cilia (46, 71). 
To perform this study, a ciliated cell line that stably expresses 5-HTR6 fused to GFP (IMCD3-
HTR6-GFP) can be used. Notably, it has been shown that Arl13b depletion results in 
defective dynamics of 5-HTR6 within cilia (44). Therefore, it is expect to observe defects in 
the ciliary transport of 5-HTR6 from cytosol to cilia when Arl13b is depleted. If Sec8 assists in 
the transport of Arl13b-containing vesicles to cilia, it is expect to observe a similar phenotype 
when Sec8 is depleted. Thus, these experiments will determine if Arl13b and/or the exocyst 
regulate ciliary cargo trafficking through the same route.  
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We intended to investigate if there was a synergistic genetic interaction between 
Arl13b and the exocyst and to study the functional relevance of their interaction using 
zebrafish as an animal model. We planned to silence the proteins through morpholinos (MO) 
injection in one stage-cell embryos of zebrafish. MOs are small antisense oligos specific for 
small RNA regions preventing the expression of a protein of interest. Nevertheless, we were 
interested in the effects of this synergistic interaction between Arl13b and the exocyst in the 
formation of the Kupffer’s vesicle (KV), the fish homologue of the mouse node. The KV is 
responsible for generating a directional fluid flow derived by motile cilia that leads to the left-
right asymmetry of the internal organs during development (72). Therefore, we wanted to 
assess how cilia formation in the KV is affected between the stages of 8 and 12 somites, 
period in the fish development when the KV starts to form and the cells start to ciliate. To 
investigate if there is a synergy between the two genes, the embryos are submitted to a sub-
optimal dose of both MOs for Arl13b and exocyst simultaneously, in which the embryos do 
not present any phenotype, when compared to control-injected embryos. We planned to 
measure the cilia length in the KV of the double morphants and to correlate shorter cilia with 
left-right patterning defects eventually detected.  
It is known that Sec8 knockout mice display early embryonic lethality (73). Depletion 
of Sec8 in zebrafish embryos could also cause early development defects that would 
preclude the analysis of specific phenotypes (60). Therefore, we decided to use a MO for 
Sec10, since this subunit is known to be the core of the exocyst complex and this silencing 
was alredy successfully acomplished in zebrafish (59). Thus, to investigate the synergistic 
effects of double morphant Arl13b-Sec10 in the KV cilia, we started by optimizing the dose of 
each MO in order to reach a sub-optimal dose that does not cause any noticeable 
phenotype. This optimization was done by injecting 3 different doses of MO for Arl13b in one 
stage-cell embryos and by looking at 3 different parameters; death rate, body curvature and 
left-right asymmetry of the heart. The sub-optimal dose was achieved when the percentage 
of dead embryos was lower than 50%, no body curvature phenotype was seen and there 
was at least 90% of left-sided heart morphants (42). The sub-optimal dose for Arl13b was 
achieved injecting 0,15 mM of MO in zebrafish embryos. Unfortunately, the sub-optimal dose 
for Sec10 MO has not yet been determined due to limitation of time. Therefore, this aim will 
have to be continued.  
Our collaborator Dr. Josh Lipschutz, an expert in exocyst, performed a similar 
experiment in the meantime but focusing only their observations in cilia-related phenotypes 
like curved tail, small eyes and pericardial edema. Although they have not analysed KV and 
other ciliated organs that we intend to look at, their experiment showed that there is a 
synergistic genetic interaction between Arl13b-Sec10 for cilia-related events. This result 
indicates that these genes act in a common or parallel pathways. 
!28 
In conclusion, our study reveals a novel effector of Arl13b, the exocyst. We showed 
that the interaction between exocyst and Arl13b is mediated by a direct interaction with Sec8. 
Besides we also proved that both the N- and C- terminal domain of Arl13b are necessary for 
the interaction with Sec8. Moreover, we showed that Exo70 is co-immunoprecipitated with 
Arl13b. We observed for the first time, that Sec8 causes ciliogenesis abrogation in 
mammalian cell line. Taking into account these results, and the results from our collaborator 
that there is a synergistic genetic interaction between Arl13b and Sec10, and considering 
that Arl13b regulates endocytic recycling trafficking through the ERC (22), we propose a 
model where Arl13b and the exocyst are involved in the transport of ciliary cargo derived 
from the ERC. In our model, Sec8 is responsible for sorting and transport of Arl13b-
containing vesicles to the periciliary region. Exo70 could be requiredfor the fusion of these 
vesicles to the ciliary pocket membrane, since Exo70 is a membrane-bound protein known to 
be involved in plasma membrane remodelling and actin dynamics (74). A similar role was 
proposed for Rab10, which localizes at the base of nascent cilia with exocyst subunits, and 
forms a complex with Sec8 (66). Future studies will explore if this model is correct and 
should bring more insights in the role of Arl13b in ciliogenesis. 
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Supplementary data 
 
 
 
 
 
Supplementary Figure 1 - Sec8 is an Arl13b effector in non-ciliated cells. Total cell 
extracts from HeLa cells were immunoprecipitated with anti-Arl13b antibody in the presence 
of non-hydrolyzable GTP (GTPγS) or GDP. Immunoprecipitates were analyzed by SDS-
PAGE and immunoblot with anti-Sec8 antibody. 
 
 
 
Supplementary Figure 2 - Schematic representation of the different domains of Arl13b. 
The Arf domain is responsible for the molecular exchanges between GTP and GDP, 
changing the protein between an inactive and active state to bind effectors. On the other 
hand coiled coil domain and proline rich-region are responsible for stabilize the protein 
conformation to allow the molecular switch between GTP and GDP. The mutant Arl13b [1-
193]-EGFP contains only the Arf domain of the protein and the mutant Arl13b [194-428]-
EGFP contains the coiled coil domain and the proline-rich region. 
!-2- 
 
Supplementary Figure 3 – Arl13b-GFP pull-down efficiency. Cell lysates from HeLa cells 
(800 µg protein) overexpressing Arl13b-GFP full length, Arl13b[1-193]-GFP or Arl13b[194-
428]-GFP were immunoprecipitated with GFP-trap beads to pull-down the Arl13b proteins 
tagged with GFP after pre incubation with GTPγS, or GDP or without any nucleotide (No 
Nucl.). Proteins in the immunoprecipitations were resolved by SDS-PAGE and immunblot 
with anti-GFP antibody. Asterisks (*) indicate the specific band for each construct. 
 
Supplementary Figure 4 – Quantification of silencing level by qRT-PCR. (A) Percentage 
of relative mRNA expression for Arl13b determined by qRT-PCR  (B) Percentage of relative 
mRNA expression for Sec8 determined by qRT-PCR. 
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